Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy. 1995

J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
Department of Nephrology, University Hospital St. Radboud, Nijmegen, The Netherlands.

Heparan sulphate-associated anionic sites in the glomerular basement membrane were studied in rats 8 months after induction of diabetes by streptozotocin and in age- adn sex-matched control rats, employing the cationic dye cuprolinic blue. Morphometric analysis at the ultrastructural level was performed using a computerized image processor. The heparan sulphate specificity of the cuprolinic blue staining was demonstrated by glycosaminoglycan-degrading enzymes, showing that pretreatment of the sections with heparitinase abolished all staining, whereas chondroitinase ABC had no effect. The majority of anionic sites (74% in diabetic and 81% in control rats) were found within the lamina rara externa of the glomerular basement membrane. A minority of anionic sites were scattered throughout the lamina densa and lamina rara interna, and were significantly smaller than those in the lamina rara externa of the glomerular basement membrane (p<0.001 and p<0.01 for diabetic and control rats, respectively). Diabetic rats progressively developed albuminuria reaching 40.3 (32.2-62.0) mg/24 h after 8 months in contrast to the control animals (0.8 (0.2-0.9) mg/24 h, p<0.002). At the same time, the number of heparan sulphate anionic sites and the total anionic site surface (number of anionic sites x mean anionic site surface) in the lamina rara externa of the glomerular basement membrane was reduced by 19% (p<0.021) and by 26% (p<0.02), respectively. Number and total anionic site surface in the remaining part of the glomerular basement membrane (lamina densa and lamina rara interna) were not significantly changed. We conclude that in streptozotocin-diabetic rats with an increased urinary albumin excretion, a reduced heparan sulphate charge barrier/density is found at the lamina rara externa of the glomerular basement membrane.

UI MeSH Term Description Entries
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002808 Chondroitin Lyases Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C. Chondroitin AC Lyase,Chondroitin B Lyase,Chondroitin Eliminase,Chondroitin Sulfate Lyase,Chondroitinase-AC II,Chondroitinase AC II,Eliminase, Chondroitin,Lyase, Chondroitin AC,Lyase, Chondroitin B,Lyase, Chondroitin Sulfate,Lyases, Chondroitin,Sulfate Lyase, Chondroitin
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004396 Coloring Agents Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. Coloring Agent,Dye,Dyes,Organic Pigment,Stain,Stains,Tissue Stain,Tissue Stains,Organic Pigments,Pigments, Inorganic,Agent, Coloring,Inorganic Pigments,Pigment, Organic,Pigments, Organic,Stain, Tissue,Stains, Tissue
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin
D000419 Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. Albuminurias
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
January 2005, Nephron. Experimental nephrology,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
November 1995, Diabetes research and clinical practice,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
August 1997, Diabetes research and clinical practice,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
July 2012, Toxicologic pathology,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
December 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
January 1998, Journal of diabetes and its complications,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
January 2000, International journal of experimental diabetes research,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
March 1979, The Journal of experimental medicine,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
June 1985, Nihon Jinzo Gakkai shi,
J van den Born, and A A van Kraats, and M A Bakker, and K J Assmann, and H B Dijkman, and J A van der Laak, and J H Berden
November 1989, Diabetologia,
Copied contents to your clipboard!